Skip to main content

The acquisition of Allergan is a transformative move for AbbVie as we advance our mission to make a remarkable impact on patients’ lives and enhance our value as a long-term partner to those who share our vision for solving serious health issues.

With Allergan’s incorporation, in addition to Aesthetics, we have added new pillars of growth: a leading Eye Care business and an expanded Specialty product line with neuroscience, women’s health, GI and medical therapeutics.

Together, we are a team of passionate, talented minds motivated to find revolutionary solutions to real, life-changing disorders.

Two AbbVie doctors wearing goggles and holding vials
Advancing our mission

Learn how the acquisition of Allergan allows us to better serve patients today and invest in the medicines of the future.

Resources Media Contacts


AbbVie is currently reviewing all content on  As we work through the successful integration of Allergan and consolidation of content, information will be updated.


Transaction News


Media contacts

Lisa Maguire
Director, Communications and Patient Relations
Australia and New Zealand
+ 61 499 200 550
[email protected]


Kate Richards
Head of Corporate Communications
Australia and New Zealand
+61 466 420 739    
[email protected]